| 391.4 0.16 (0.04%) | 08-06 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 476.84 | 1-year : | 509.52 |
| Resists | First : | 408.25 | Second : | 436.23 |
| Pivot price | 382.03 |
|||
| Supports | First : | 362.98 | Second : | 301.99 |
| MAs | MA(5) : | 383.85 |
MA(20) : | 388.09  |
| MA(100) : | 366.66 |
MA(250) : | 342.77 |
|
| MACD | MACD : | -3.6 |
Signal : | -4.3 |
| %K %D | K(14,3) : | 72.3 |
D(3) : | 51.6 |
| RSI | RSI(14): 51.5 |
|||
| 52-week | High : | 436.23 | Low : | 272.04 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ ELV ] has closed below upper band by 13.3%. Bollinger Bands are 45.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 2 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 393.25 - 394.84 | 394.84 - 396.35 |
| Low: | 382.71 - 384.48 | 384.48 - 386.18 |
| Close: | 388.57 - 391.34 | 391.34 - 393.98 |
Operating as a major health benefits organization, Elevance Health Inc. commits to guiding consumers, families, and communities across their entire health and wellness path. It facilitates access to vital care, assistance, and tools designed to enable healthier living for approximately 118 million individuals. The company's comprehensive offerings span medical, digital, pharmaceutical, behavioral health, clinical, and other care solutions. Founded in 1944 and based in Indianapolis, Indiana, this entity adopted its current name, Elevance Health Inc., in June 2022, having previously operated as Anthem, Inc.
Thu, 06 Aug 2026
Pediatrix Medical Tops Q2 Earnings on Better Cash Collections - TradingView
Wed, 05 Aug 2026
Elevance Health Inc (ELV) Shares Surge 3.5% -- What GF Score of 90 Tells Investors - GuruFocus
Tue, 04 Aug 2026
Is Elevance Health (ELV) Entering a Major Earnings Recovery? - Yahoo Finance
Tue, 04 Aug 2026
Is Elevance Health (ELV) Positioned for Margin Recovery? - Yahoo Finance UK
Mon, 03 Aug 2026
Elevance Health, Inc. (ELV) Stock Analysis: Exploring a Potential 19.49% Upside in the Healthcare Sector - DirectorsTalk Interviews
Sun, 02 Aug 2026
Gail Boudreaux | Elevance Health CEO & Former Dartmouth Basketball Star | Britannica Money - Encyclopedia Britannica
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Healthcare Plans
|
|
| Shares Out | 217 (M) |
| Shares Float | 216 (M) |
| Held by Insiders | 0.1 (%) |
| Held by Institutions | 93.6 (%) |
| Shares Short | 6,030 (K) |
| Shares Short P.Month | 6,280 (K) |
| EPS | 22.62 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 206.99 |
| Profit Margin | 2.4 % |
| Operating Margin | 4.5 % |
| Return on Assets (ttm) | 3.8 % |
| Return on Equity (ttm) | 11.1 % |
| Qtrly Rev. Growth | 1.3 % |
| Gross Profit (p.s.) | 241.01 |
| Sales Per Share | 927.32 |
| EBITDA (p.s.) | 38.36 |
| Qtrly Earnings Growth | -13.2 % |
| Operating Cash Flow | 7,460 (M) |
| Levered Free Cash Flow | 4,310 (M) |
| PE Ratio | 17.3 |
| PEG Ratio | 1.3 |
| Price to Book value | 1.89 |
| Price to Sales | 0.42 |
| Price to Cash Flow | 11.37 |
| Dividend | 1.72 |
| Forward Dividend | 0 |
| Dividend Yield | 0.4% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|